Oligonucleotides derived from the packaging signal at the 5′ end of the viral PB2 segment specifically inhibit influenza virus in vitro

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Archives of Virology

• Publication date

  2009-04-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00705-009-0380-2PMID 19370391
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nucleotide Sequence Requirements at the 5′ End of the Influenza A Virus M RNA Segment for Efficient Virus Replication

  2009cited by this paper
• Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.

  2008cited by this paper
• In vitro and in vivo Protection against the Highly Pathogenic H5N1 Influenza virus by an Antisense Phosphorothioate Oligonucleotide

  2008cited by this paper
• Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene.

  2008cited by this paper
• Mutational Analysis of cis-Acting RNA Signals in Segment 7 of Influenza A Virus

  2008cited by this paper
• HIV drug resistance transmission threshold survey in Bangkok, Thailand

  2008cited by this paper
• Influenza Virus Protecting RNA: an Effective Prophylactic and Therapeutic Antiviral

  2008cited by this paper
• Specific Residues of the Influenza A Virus Hemagglutinin Viral RNA Are Important for Efficient Packaging into Budding Virions

  2007cited by this paper
• Peptide-Mediated Interference with Influenza A Virus Polymerase

  2007cited by this paper
• Highly Conserved Regions of Influenza A Virus Polymerase Gene Segments Are Critical for Efficient Viral RNA Packaging

  2007influential reference
• Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.

  2007cited by this paper
• Mutational Analyses of Packaging Signals in Influenza Virus PA, PB1, and PB2 Genomic RNA Segments

  2007influential reference
• Codon conservation in the influenza A virus genome defines RNA packaging signals

  2007cited by this paper
• Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention

  2007cited by this paper
• RNA interference against viruses: strike and counterstrike

  2007cited by this paper
• Antiviral agents active against influenza A viruses

  2006cited by this paper
• Influenza virus pleiomorphy characterized by cryoelectron tomography

  2006cited by this paper
• Architecture of ribonucleoprotein complexes in influenza A virus particles

  2006cited by this paper
• Hierarchy among Viral RNA (vRNA) Segments in Their Role in vRNA Incorporation into Influenza A Virions

  2006influential reference
• Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.

  2006cited by this paper
• Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

  2006cited by this paper
• Oligonucleotides as antivirals: dream or realistic perspective?

  2006cited by this paper
• Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission.

  2006influential reference
• Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers

  2006cited by this paper
• Contributions of Two Nuclear Localization Signals of Influenza A Virus Nucleoprotein to Viral Replication

  2006cited by this paper
• Inhibition of HIV-1 Replication by Oligonucleotide Analogues Directed to the Packaging Signal and Trans-Activating Response Region

  2006cited by this paper
• Inhibition of Infectious Human Immunodeficiency Virus Type 1 Virions via Lentiviral Vector Encoded Short Antisense RNAs

  2006cited by this paper
• The CPSF30 Binding Site on the NS1A Protein of Influenza A Virus Is a Potential Antiviral Target

  2006cited by this paper
• Oligonucleotides as antivirals: dream or realistic perspective?

  2006cited by this paper
• Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses.

  2005cited by this paper
• Evolution of influenza polymerase: nucleotide sequence of the PB2 gene of A/Chile/1/83 (H1N1)

  2005cited by this paper
• cis-Acting Packaging Signals in the Influenza Virus PB1, PB2, and PA Genomic RNA Segments

  2005cited by this paper
• Importance of both the Coding and the Segment-Specific Noncoding Regions of the Influenza A Virus NS Segment for Its Efficient Incorporation into Virions

  2005cited by this paper
• The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5' end of the PB2 segment.

  2005influential reference
• The retroviral RNA dimer linkage: different structures may reflect different roles

  2004cited by this paper
• Influenza: Emergence and Control

  2004cited by this paper
• Assembly and budding of influenza virus

  2004cited by this paper
• Nucleic Acid-Based Immune System: the Antiviral Potential of Mammalian RNA Silencing

  2003cited by this paper
• Selective incorporation of influenza virus RNA segments into virions

  2003cited by this paper
• Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

  2003cited by this paper
• RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription

  2003influential reference
• Exploitation of Nucleic Acid Packaging Signals To Generate a Novel Influenza Virus-Based Vector Stably Expressing Two Foreign Genes

  2003cited by this paper
• The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication.

  2002cited by this paper
• Evidence for Segment-Nonspecific Packaging of the Influenza A Virus Genome

  2002cited by this paper
• Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system.

  2002cited by this paper
• Antisense therapy of influenza.

  2001cited by this paper
• Antisense RNA sequences targeting the 5′ leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle

  2000cited by this paper
• Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.

  2000cited by this paper
• In vitro and in vivo anti-influenza A virus activity of antisense oligonucleotides.

  1999cited by this paper
• Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A

  1999cited by this paper
• Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro.

  1998cited by this paper
• Antiviral activity of influenza virus M1 zinc finger peptides

  1996cited by this paper
• Orthomyxoviridae: The Viruses and Their Replication.

  1996cited by this paper
• Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner.

  1996cited by this paper
• Identification and characterization of a coronavirus packaging signal

  1992cited by this paper
• An influenza virus containing nine different RNA segments.

  1991cited by this paper
• Influenza

  1925cited by this paper

• Decoding the role of RNA sequences and their interactions in influenza A virus infection and adaptation

  2024cites this paper
• Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors

  2023influential citation
• Antiviral Activity of Oligonucleotides Targeting the SARS-CoV-2 Genomic RNA Stem-Loop Sequences within the 3′-End of the ORF1b

  2022cites this paper
• Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2

  2022cites this paper
• Contribution of RNA-RNA Interactions Mediated by the Genome Packaging Signals for the Selective Genome Packaging of Influenza A Virus

  2022cites this paper
• Identification and targeting of a pan-genotypic influenza A virus RNA structure that mediates packaging and disease

  2021cites this paper
• Advancements in Nucleic Acid Based Therapeutics against Respiratory Viral Infections

  2018cites this paper
• Conserved secondary structures predicted within the 5′ packaging signal region of influenza A virus PB2 segment

  2018cites this paper
• Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance

  2016cites this paper
• Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication

  2016cites this paper
• Taming Influenza Virus: Role of Antisense Technology.

  2015cites this paper
• Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.

  2015cites this paper
• Delivery of oligonucleotides with lipid nanoparticles.

  2015cites this paper
• Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication.

  2015cites this paper
• Antiviral strategies against influenza virus: towards new therapeutic approaches

  2014cites this paper
• Engineering influenza viral vectors

  2013cites this paper
• Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.

  2011cites this paper
• Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.

  2011cites this paper
• Mécanisme d’incorporation des segments d’ARNv d’un virus influenza A aviaire : comparaison avec un virus humain et implication pour le réassortiment génétique

  2011influential citation
• Therapeutic targets for influenza – perspectives in drug development

  2010cites this paper
• Genome packaging in influenza A virus.

  2010cites this paper